Federal Judge Rejects Eli Lilly’s Confidential Settlement in Telehealth Drug Dispute, Citing Lack of Transparency
An Indiana federal judge recently declined to approve a confidential settlement between Eli Lilly and a telehealth company, citing insufficient details about the agreement. The dispute centers on allegations that the telehealth company was marketing unauthorized versions of Eli Lilly’s weight-loss medications. The judge’s refusal highlights the ongoing tension in pharmaceutical intellectual property cases, especially…